Treatment with mononuclear cell populations improves post-infarction cardiac function but does not reduce arrhythmia susceptibility.
PloS one
View this publicationPloS one
View this publicationThe New England journal of medicine
View this publicationFrontiers in immunology
View this publicationTranslational psychiatry
View this publicationJournal of pain research
View this publicationJournal of molecular medicine (Berlin, Germany)
View this publicationLeukemia
View this publicationFrontiers in immunology
View this publicationClinical and experimental rheumatology
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publication